BR112016026443A2 - compostos heterocíclicos deuterados, seus usos, e composição farmacêutica - Google Patents
compostos heterocíclicos deuterados, seus usos, e composição farmacêuticaInfo
- Publication number
- BR112016026443A2 BR112016026443A2 BR112016026443A BR112016026443A BR112016026443A2 BR 112016026443 A2 BR112016026443 A2 BR 112016026443A2 BR 112016026443 A BR112016026443 A BR 112016026443A BR 112016026443 A BR112016026443 A BR 112016026443A BR 112016026443 A2 BR112016026443 A2 BR 112016026443A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- heterocyclic compounds
- deuterated
- deuterated heterocyclic
- compounds
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461992717P | 2014-05-13 | 2014-05-13 | |
US61/992,717 | 2014-05-13 | ||
PCT/EP2015/060447 WO2015173225A1 (en) | 2014-05-13 | 2015-05-12 | Deuterated heterocyclic compounds and their use as imaging agents |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112016026443A2 true BR112016026443A2 (pt) | 2017-08-15 |
BR112016026443A8 BR112016026443A8 (pt) | 2021-07-06 |
BR112016026443B1 BR112016026443B1 (pt) | 2023-07-04 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016030787A2 (pt) | entidade química, composição farmacêutica e seu uso | |
BR112016016158A2 (pt) | Derivados de heterociclila bicíclicos como inibidores de irak4, sua composição farmacêutica e seus usos | |
CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
BR112016023422A2 (pt) | Dispersão seca por spray, composição farmacêutica e seus usos, kit e comprimido | |
BR112017004612A2 (pt) | compostos, composição farmacêutica, usos de um composto, e kit | |
BR112016027722A2 (pt) | compostos contendo grupo autoimulativo e seu uso | |
IL247062A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical preparations containing them | |
BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
BR112016018062A2 (pt) | compostos terapêuticos, composição farmacêutica e usos | |
DK3297605T3 (da) | Topiske, farmaceutiske sammesætninger | |
DK3229810T3 (da) | Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler | |
DK3143011T3 (da) | Deutererede heterocykliske forbindelser og deres anvendelse som billeddannende stoffer | |
BR112016023628A2 (pt) | composições farmacêuticas. | |
BR112016023341A2 (pt) | composição desinfetante de ação rápida | |
DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
BR112016026879A2 (pt) | Composição farmacêutica líquida | |
BR112016025659A2 (pt) | compostos, seus usos, e composições farmacêuticas para induzir condrogênese | |
BR112016024298A2 (pt) | compostos de quinoxalina e seus usos. | |
DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
DK3554534T3 (da) | Farmaceutisk sammensætning omfattende insulin | |
DK3199161T3 (da) | Farmaceutisk præparat | |
BR112016026552A2 (pt) | derivados de carboxamida, seus usos, composição farmacêutica, e combinação | |
BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
DK3278801T3 (da) | Farmaceutisk sammensætning indeholdende mirabegron |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/05/2015, OBSERVADAS AS CONDICOES LEGAIS |